Arizona CERTQTdrugs.orgTorsades.orgCERTs
Arizona CERT Home Page Picture of Physicians
University of Arizona Health Sciences Center
Arizona CERT Home
About Us
Drug Interactions
Patients
Physicians & Pharmacists
QTdrugs.org
Torsades.org

 

 

About Us
Faculty Profile

Dr. Raymond L. Woosley, MD, PhD

Raymond L. Woosley is Vice President for Health Sciences at the University of Arizona.

Dr. Woosley earned a Ph.D. in Pharmacology from the University of Louisville (1967) and an M.D. degree from the University of Miami (1971). Dr. Woosley completed Post-doctoral training at the University of Louisville in Pharmacology and at Vanderbilt University in Clinical Pharmacology.

Following graduate school, he served as the first scientist employed by Meyer Laboratories (now Glaxo-Wellcome, Inc.). After returning to study medicine, he graduated from the University of Miami School of Medicine and then specialized in Internal Medicine and Clinical Pharmacology at Vanderbilt University. He remained on the faculty and rose to the rank of Professor of Medicine and Pharmacology.

From 1988 to 2001, he was Chairman of the Department of Pharmacology at Georgetown University. In 2001 he assumed the position of Associate Dean for Clinical Research. He has served on many national advisory committees for the NIH, Veterans Administration, the US Pharmacopeial Convention, the Cardiorenal Advisory Committee of the Food and Drug Administration, the Institute of Medicine (National Academy of Sciences) and chairman of the Joint Advisory Committee on Cardiovascular Drugs for the American Heart Association and the American College of Cardiology. He has served as ad hoc consultant for numerous FDA advisory committees and is currently a Special Consultant for the FDA and a member of the Director's Advisory Committee on Clinical Research for the NIH's National Center for Research Resources.

Dr. Woosley's research has investigated the basic and clinical pharmacology of antiarrhythmic drugs and he is considered an international authority on the drug treatment of arrhythmias. He has demonstrated the importance of active drug metabolites, stereoisomerism and pharmacogenetic differences in drug metabolism as factors influencing the pharmacologic and clinical response to antiarrhythmic drugs, beta adrenergic antagonists, antimalarials and, more recently, antihistamines such as terfenadine. His research in recent years has identified the mechanisms responsible for the greater risk of drug-induced arrhythmias in women and he is currently a member of the Board of the Society for Advancement of Women's Health Research. His research has been reported in over 250 publications including 135 original articles, 46 book chapters and 61 invited reviews.

In March of 1990, he received the Rawls-Palmer Award for his contributions to medicine by the American Society of Clinical Pharmacology and Therapeutics. He was selected by practicing physicians to be listed in The Best Doctors in America. In 1995, he was appointed Director of the Institute for Cardiovascular Sciences at Georgetown University and in 1998 he was appointed Director of the General Clinical Research Center at Georgetown.

In addition, Dr. Woosley is Past-president of the Association for Medical School Pharmacology (a society of chairs of pharmacology) and in 2000-2001 served as the President of The American Society for Clinical Pharmacology and Therapeutics (ASCPT). In October of 1999 he was selected to direct one of four Centers for Education and Research in Therapeutics funded by the Agency for Health Care Policy and Research.

Return to Faculty Profile

 

 
 

The University of Arizona Center for Education and Research on Therapeutics
Arizona Health Sciences Center
Tucson, Arizona  85724-5018

Funded in part by AHCPR grant 1 U18 HS10385-01

Disclaimer and Waiver
The information presented is intended solely for the purpose of providing general information about health related matters.  It is not intended for any other purpose, including, but not limited to, medical or pharmaceutical advice and/or treatment, nor is it intended to substitute for the users' relationships with their own health care/pharmaceutical providers.  To that extent, by continued use of this program, the user affirms the understanding of the purpose and releases the University of Arizona, State of Arizona and Arizona Board of Regents from any claims arising out of his/her use of the website.